Developing a multivariate prediction model of antibody features associated with protection of malaria-infected pregnant women from placental malaria
June 29, 2021
Background: Plasmodium falciparum causes placental malaria, which results in adverse outcomes for mother and child. P. falciparum-infected erythrocytes that express the parasite protein…
Seeking an optimal dosing regimen for OZ439/DSM265 combination therapy for treating uncomplicated falciparum malaria
June 28, 2021
Background: The efficacy of artemisinin-based combination therapies (ACTs), the first-line treatments for uncomplicated falciparum malaria, has been declining in malaria-endemic countries…
Global economic costs due to vivax malaria and the potential impact of its radical cure: A modelling study
June 1, 2021
Background: In 2017, an estimated 14 million cases of Plasmodium vivax malaria were reported from Asia, Central and South America, and…